111 related articles for article (PubMed ID: 14726694)
1. SAGE identification and fluorescence imaging analysis of genes and transcripts in melanomas and precursor lesions.
Smith AP; Weeraratna AT; Spears JR; Meltzer PS; Becker D
Cancer Biol Ther; 2004 Jan; 3(1):104-9. PubMed ID: 14726694
[TBL] [Abstract][Full Text] [Related]
2. Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE).
Matsuzaki Y; Hashimoto S; Fujita T; Suzuki T; Sakurai T; Matsushima K; Kawakami Y
J Immunother; 2005; 28(1):10-9. PubMed ID: 15614040
[TBL] [Abstract][Full Text] [Related]
3. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes.
McDonald SL; Edington HD; Kirkwood JM; Becker D
Cancer Biol Ther; 2004 Jan; 3(1):110-20. PubMed ID: 14726712
[TBL] [Abstract][Full Text] [Related]
5. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas.
Smith AP; Hoek K; Becker D
Cancer Biol Ther; 2005 Sep; 4(9):1018-29. PubMed ID: 16251803
[TBL] [Abstract][Full Text] [Related]
6. Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.
Yang P; Farkas DL; Kirkwood JM; Abernethy JL; Edington HD; Becker D
Mol Med; 1999 Dec; 5(12):785-94. PubMed ID: 10666478
[TBL] [Abstract][Full Text] [Related]
7. Suppressing the high-level expression and function of ATM in advanced-stage melanomas does not sensitize the cells to ionizing radiation.
Moschos SJ; Dodd NR; Jukic DM; Fayewicz SL; Wang X; Becker D
Cancer Biol Ther; 2009 Oct; 8(19):1815-25. PubMed ID: 19684476
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma.
Yang P; Becker D
Int J Oncol; 2000 Nov; 17(5):913-9. PubMed ID: 11029492
[TBL] [Abstract][Full Text] [Related]
9. Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.
Weeraratna AT; Becker D; Carr KM; Duray PH; Rosenblatt KP; Yang S; Chen Y; Bittner M; Strausberg RL; Riggins GJ; Wagner U; Kallioniemi OP; Trent JM; Morin PJ; Meltzer PS
Oncogene; 2004 Mar; 23(12):2264-74. PubMed ID: 14755246
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
11. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
[TBL] [Abstract][Full Text] [Related]
13. Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.
Takeuchi H; Kuo C; Morton DL; Wang HJ; Hoon DS
Cancer Res; 2003 Jan; 63(2):441-8. PubMed ID: 12543800
[TBL] [Abstract][Full Text] [Related]
14. Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression.
Hustinx SR; Cao D; Maitra A; Sato N; Martin ST; Sudhir D; Iacobuzio-Donahue C; Cameron JL; Yeo CJ; Kern SE; Goggins M; Mollenhauer J; Pandey A; Hruban RH
Cancer Biol Ther; 2004 Dec; 3(12):1254-61. PubMed ID: 15477757
[TBL] [Abstract][Full Text] [Related]
15. SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas.
Moschos SJ; Smith AP; Mandic M; Athanassiou C; Watson-Hurst K; Jukic DM; Edington HD; Kirkwood JM; Becker D
Oncogene; 2007 Jun; 26(29):4216-25. PubMed ID: 17297476
[TBL] [Abstract][Full Text] [Related]
16. The Genetic Evolution of Melanoma from Precursor Lesions.
Shain AH; Yeh I; Kovalyshyn I; Sriharan A; Talevich E; Gagnon A; Dummer R; North J; Pincus L; Ruben B; Rickaby W; D'Arrigo C; Robson A; Bastian BC
N Engl J Med; 2015 Nov; 373(20):1926-36. PubMed ID: 26559571
[TBL] [Abstract][Full Text] [Related]
17. Melanoma precursor lesions and borderline melanomas.
Briggs JC
Histopathology; 1985 Dec; 9(12):1251-62. PubMed ID: 3913633
[TBL] [Abstract][Full Text] [Related]
18. Infrequent expression of the MAGE gene family in uveal melanomas.
Mulcahy KA; Rimoldi D; Brasseur F; Rodgers S; Liénard D; Marchand M; Rennie IG; Murray AK; McIntyre CA; Platts KE; Leyvraz S; Boon T; Rees RC
Int J Cancer; 1996 Jun; 66(6):738-42. PubMed ID: 8647642
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas.
Cowan JM; Halaban R; Francke U
J Natl Cancer Inst; 1988 Sep; 80(14):1159-64. PubMed ID: 3166071
[TBL] [Abstract][Full Text] [Related]
20. Expression of MAGE genes in primary and metastatic cutaneous melanoma.
Brasseur F; Rimoldi D; Liénard D; Lethé B; Carrel S; Arienti F; Suter L; Vanwijck R; Bourlond A; Humblet Y
Int J Cancer; 1995 Nov; 63(3):375-80. PubMed ID: 7591235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
